2m 2m 2m 2m 2m 2m 2m
Viking Therapeut (VKTX)
NASDAQ
$25.89+$0.06 (+0.22%)
Price as of Oct 22, 2026 7:59 PM EDT- $3.3BMarket Cap
- -16.04%1-Year Change
- BiotechnologyIndustry
Viking Therapeut (VKTX)
$25.89+$0.06 (+0.22%)
VKTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.83 | ||
Change | -$0.33 (-1.24%) | ||
Open | $26.36 | ||
High | $26.79 | ||
Low | $25.66 | ||
Previous Close | $26.38 | ||
Volume | 3,530,547 | ||
30-Day Average Volume | 9,244,139 | ||
1-Week Change | 3.57% | ||
1-Month Change | -12.39% | ||
1-Year Change | -16.04% | ||
3-Year Change | 163.01% | ||
5-Year Change | 362.81% | ||
Fundamentals | |||
Shares Outstanding | 125.7M | ||
Total Assets | $521.9M | ||
Market Cap | $3.3B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $30,000.00 | ||
Net Income | -$128.0M | ||
Free Cash Flow | -$125.2M | ||
EBIT | -$128.0M | ||
EBITDA | -$128.0M | ||
Net Working Capital | $407.9M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 106,331 | ||
P/B | 8 | ||
P/E | -24 | ||
PEG | -1 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue